China Resources Double-Crane Pharmaceutical (600062.SH): Vortioxetine Hydrobromide API Receives Approval Notice for Chemical API Marketing Application

Zhitong Finance APP News: China Resources Double-Crane (600062.SH) announced that recently, its controlling subsidiary China Resources Double-Crane Xiangzhong Pharmaceutical (Hunan) Co., Ltd. (hereinafter referred to as "Double-Crane Xiangzhong") received the "Chemical Active Pharmaceutical Ingredient Marketing Application Approval Notification" for Vortioxetine Hydrobromide issued by the National Medical Products Administration (hereinafter referred to as the "NMPA").